Summary
Severe degeneration of neuronal processes, including axons and dendrites, as well as accumulation of lipofuscin-like dense bodies have been induced in rats by continuous intraventricular administration by infusion of a protase inhibitor, leupeptin. The aggregation of degenerated processes in neuropils mingled with glial cells and their processes resembled the aggregation of degenerated neurites that are important constituents of the senile plaque of Alzheimer's disease. The present findings provide morphological evidence supporting the hypothesis that protease inhibitors participate in the process of senile plaque formation.
Similar content being viewed by others
References
Abraham CR, Selkoe DJ, Potter H (1988) Immunochemical identification of the serine protease inhibitor α-1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52:487–501
Chang LW, Tiemeyer TM, Wenger GR, McMillan DE, Reuhl KR (1982) Neuropathology of trimethyltin intoxication. Environ Res 29:445–458
Ishikawa T, Furuno K, Kato K (1983) Ultrastructural studies on autolysosomes in rat hepatocytes after leupeptin treatment. Exp Cell Res 144:15–24
Ivy GO, Schottler F, Wenzel J, Baudry M, Lynch G (1984) Inhibitors of lysosomal enzymes: accumulation of lipofuscin-like dense bodies in the brain. Science 226:985–987
Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H (1988) Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 331: 530–532
Lampert PW (1967) A comparative electron microscopic study of reactive, degenerating, regenerating, and dystrophic axons. J Neuropathol Exp Neurol 26:345–368
Luse SA, Smith KR Jr (1964) The ultrastructure of senile plaques. Am J Pathol 44:553–563
Miyoshi K, Takauchi S (1977) Chronic tellurium intoxication in rats. Folia Psychiatr Neurol Jpn 31:111–118
Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F, Cordell B (1988) A new A4 amyloid mRNA contains a domain homologous to serine protease inhibitors. Nature 331:525–527
Roots BI (1983) Neurofilament accumulation induced in synapses by leupeptin. Science 221:971–972
Schlaepfer WW, Zimmerman UJP (1984) Calcium-activated protease and the regulation of the axonal cytoskeleton. In: Elam JS, Cancalon P (eds) Axonal transport in neuronal growth and regeneration. Plenum Press, New York, pp 261–273
Spencer PS, Sterman AB, Horoupian D, Bischoff M, Foser GV (1979) Neurotoxic changes in rats exposed to the fragrance compound acetyl ethyl tetramethyl tetralin. Neurotoxicology 1:221–237
Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff L, Gusella JF, Neve RL (1988) Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331:528–530
Tashiro T, Ishizaki Y (1982) A calcium-dependent protease selectively degrading the 160,000M r component of neurofilament is associated with the cytoskeletal preparation of the spinal cord and has an endogenous inhibitory factor. FEBS Lett 141:41–44
Terry RD, Gonatas NK, Weiss M (1964) Ultrastructural studies in Alzheimer's presenile dementia. Am J Pathol 44:269–297
Umezawa H, Aoyagi T (1977) Activities of proteinase inhibitors of microbial origin. In: Barrett AJ (ed) Proteinases in mammalian cells and tissues. Elsevier/North-Holland, Amsterdam, pp 637–662
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takauchi, S., Miyoshi, K. Degeneration of neuronal processes in rats induced by a protease inhibitor, leupeptin. Acta Neuropathol 78, 380–387 (1989). https://doi.org/10.1007/BF00688174
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00688174